Pfizer And Icagen Form Pain Pact | Chemical & Engineering News
Volume 85 Issue 34 | p. 25 | Concentrates
Issue Date: August 20, 2007

Pfizer And Icagen Form Pain Pact

Department: Business | Collection: Economy

Icagen and Pfizer will collaborate to discover and develop compounds targeting three ion channels that are critical to the generation of electrical signals in nerve fibers that modulate pain. Pfizer will provide $38 million in funding during the first two years of the program, a figure that includes a $12 million up-front fee and a $15 million equity investment in Icagen. Icagen, based in Research Triangle Park, N.C., believes that "at least three unique products" could emerge from the pact.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment